Synopsis:

In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of technology and biotech, emphasizing the importance of adaptability and diverse partnerships in driving innovation. Gibson's journey from pursuing an MD-PhD program with a focus on merging engineering and medicine to founding Recursion showcases his deep understanding of the evolving biotech landscape. His experience navigating the capital markets and proactive decision-making in response to market conditions offers valuable lessons for entrepreneurs in the industry. The episode delves into the challenges and opportunities in the biotech sector, highlighting the transformative potential of technology and the significance of embracing entrepreneurship and risk-taking. Gibson's emphasis on building diverse teams and the impact of partnerships serves as a compelling reason for entrepreneurs and leaders in the biotech industry to listen to this episode, providing valuable insights and strategies for navigating the rapidly changing biotech landscape.

Biography:

Chris Gibson developed the technology and approach that seeded Recursion as part of his MD/PhD work in the lab of Co-Founder Dr. Dean Li (current President of Merck Research Labs) while at the University of Utah. After completing his Ph.D., Chris left medical school to build Recursion into the rapidly growing company it is today. Chris is a graduate of Rice University with degrees in bioengineering and management.

Chris serves on the Board of BioHive, the public-private partnership driving expansion of Utah's life-science ecosystem, the fastest growing in the nation. Chris is also active as an advisor and mentor, both formally and informally, of many young biotech founders. Chris enjoys cycling on both the road and the trails that cut through Utah's great wilderness, as well as spending time with family.